Action

VEGFRs

Alt Name

Approval Jurisdiction

2015 FDA 2015 EMA

Approved for clinical use

Thyroid cancer (DTC) kidney cancer

Brutto

CAS

417716-92-8

Commercial Vendor

Eisai

Compound Image

Lenvatinib.png

Compound name

Lenvatinib

InChI

InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,

InChI Key

WOSKHXYHFSIKNG-UHFFFAOYSA-N

MW

426.90

PubChem CID

9823820

Reference

Reference 2

SMILES

COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl

Approved Drug List

1